New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc and Germany's BioNTech, Prime Minister Jacinda Ardern said on Wednesday (February 3).
New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc and Germany's BioNTech, Prime Minister Jacinda Ardern said on Wednesday (February 3).
How small pacific nations have managed to avoid a major health crisis during the pandemic.
A new study that just came out is showing that the Pfizer vaccine is successful at reducing the symptomatic spread by 90%.